Ctc Bio, Inc.

Lg Electronics Inc.

Hyun-Jung Park

Bong-Sang Lee

Hyun-jun Kim

Seong-Eun Lee

Hong Ryeol Jeon

Dong-Jin Lee

Seong-Shin Kwak

Jung-Hwa Kim

Guk-Chan Lim

Do-Woo Kwon

Hong-Ryeol Jeon

Man-Soo Sin

Sun-Ahe Lee

Joo-Yong Lee

Hung-Chol Chin

Yoo-Seung Yang

Dong-Chul Jin

Sang-Mo Park

Haeng-Chul Kwak

Jeong-Hwa Yoo

Park Sang-Mo

The present invention provides a pharmaceutical formulation comprising clomipramine or its pharmaceutically acceptable salt (preferably, clomipramine hydrochloride) as the first active ingredient, and sildenafil or its pharmaceutically acceptable salt (preferably, sildenafil citrate) as the second active ingredient, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation. In particular, the present invention provides a pharmaceutical formulation comprising the above two active ingredients and manufactured by using a wet granulation method, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation.

Pharmaceutical composition containing clomipramine and preparation method therefor

A method of controlling a mobile terminal, and which includes controlling, via a Windows processor, a plurality of peripheral devices of the mobile terminal; switching, via the Windows processor, the mobile terminal into a sleep state; granting, via an arbiter control processor, a control authority for controlling predetermined peripheral devices among the plurality of peripheral device to a 3G modem when the mobile terminal is switched into the sleep state; receiving, via a communication unit on the mobile terminal, an incoming call; and managing, via the 3G modem, circuit data and the predetermined peripheral devices for the incoming call.

Method of processing a call in a mobile terminal

Growing community of inventors

Gyeonggi-do, South Korea

Hyun-Jung Park